Press Releases

Results Found (130)
October 19, 2009
YISSUM INTRODUCES NOVEL NANOTECHNOLOGY FOR REVOLUTIONIZING IMAGING USING T-RAYS

The novel device will have 400 times higher gain than THz quantum cascade lasers, the only coherent T-ray sources existing today. This invention will make T-ray based cameras and spectrometers practical, ushering a new era in security and medical...

July 14, 2009
YISSUM LICENSES STEM CELL TECHNOLOGIES FOR SPINAL THERAPY TO THERACELL, INC.

Yissum announced that it has licensed a novel package of stem cell related technologies to TheraCell, Inc., which will further develop and commercialize the technology for advanced regenerative medicine procedures such as spinal fusion. The...

June 24, 2009
YISSUM SPIN-OFF ATOX BIO AND FAST-TRACK DRUGS & BIOLOGICS SIGN AN R&D...

The collaboration is funded by the Israel-U.S. binational BIRD Foundation

June 15, 2009
YISSUM SIGNS A COLLABORATION AGREEMENT WITH AURUM VENTURES MKI FOR THE...

The technology was developed by Prof. Simon Benita at the Hebrew University's School of Pharmacy.

June 9, 2009
YISSUM INTRODUCES NOVEL COMPOUND FOR THE TREATMENT OF OSTEOPOROSIS

Professor Itai Bab and Professor Raphael Mechoulam, from the School of Pharmacy at the Hebrew University of Jerusalem, invented a new drug candidate for the treatment of osteoporosis that both inhibits bone resorption and stimulates bone formation.

May 25, 2009
Z-CUBE AND YISSUM SIGN A LICENSING AGREEMENT FOR THE DEVELOPMENT OF AN...

Z-Cube has received the worldwide exclusive right to develop and commercialize the technology for pain applications and will sponsor a research program to be conducted by Professor Elka Touitou from the Hebrew University's Faculty of Medicine.

April 6, 2009
YISSUM APPOINTS YAACOV MICHLIN AS CHIEF EXECUTIVE OFFICER

Yissum announced today the appointment of Yaacov Michlin as Chief Executive Officer, effective May 1, 2009. The Company also announced that Yehuda Yarmut, who until recently was Executive Vice President Licensing & IP, was promoted and appointed...

March 30, 2009
MERCK KGAA AND YISSUM SIGN R&D COLLABORATION AGREEMENT

Merck to sponsor three-year joint R&D program with Yissum's spin-off, QLight Nanotech, for the development of novel semiconductor nanoparticles technology for optical applications

March 19, 2009
YISSUM LICENSES TO VAN LEER VENTURES A SOFTWARE PLATFORM FOR MAXIMIZING PC...

Van Leer Ventures Establishes Valensum to Develop the Technology

February 4, 2009
YISSUM ANNOUNCES NANOTECHNOLOGY FOR INCREASED BIOAVAILABILITY OF COMPOUNDS...

Professor Nissim Garti from the Casali Institute of Applied Chemistry, Institute of Chemistry at the Hebrew University of Jerusalem has received the 2009 American Oil Chemists’ Society (AOCS) Stephen S. Chang Award for his invention of novel...

December 17, 2008
YISSUM LAUNCHES CLEANTECH PROGRAMME IN SUPPORT OF TECHNOLOGIES DEVELOPED AT...

Initial cleantech inventions chosen include technologies aimed at reducing polluting effects of fossil fuels and creating alternative clean energy sources

December 15, 2008
YISSUM SUBSIDIARY JEXYS PHARMACEUTICALS ANNOUNCES STRATEGIC R&D...

Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem, announces today that its subsidiary Jexys Pharmaceuticals has signed a strategic research and development agreement with Teva Pharmaceuticals Industries Ltd. Under the...